$NKLA
Nikola Corp Stock $nkla

$nkla Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000173128922000085 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$1.887M	$0.00
YoY Change		-100.0%
Cost Of Revenue	$1.456M	$0.00
YoY Change		-100.0%
Gross Profit	$431.0K	$0.00
YoY Change		-100.0%
Gross Profit Margin	22.84%
Selling, General & Admin	$77.18M	$65.43M
YoY Change	17.97%	724.54%
% of Gross Profit	17907.89%
Research & Development	$74.56M	$55.16M
YoY Change	35.16%	129.11%
% of Gross Profit	17298.61%
Depreciation & Amortization	$3.111M	$1.805M
YoY Change	72.35%	28.2%
% of Gross Profit	721.81%
Operating Expenses	$151.7M	$120.6M
YoY Change	25.83%	276.7%
Operating Profit	-$151.3M	-$120.6M
YoY Change	25.47%	276.88%
Interest Expense	-$211.0K	-$9.000K
YoY Change	2244.44%	-114.52%
% of Operating Profit
Other Income/Expense, Net	$1.833M	$219.0K
YoY Change	736.99%	92.11%
Pretax Income	-$150.1M	-$119.4M
YoY Change	25.7%	260.32%
Income Tax	$0.00	$1.000K
% Of Pretax Income
Net Earnings	-$152.9M	-$120.2M
YoY Change	27.21%	262.71%
Net Earnings / Revenue	-8104.98%
Basic Earnings Per Share	-$0.37	-$0.31
Diluted Earnings Per Share	-$0.37	-$0.31
COMMON SHARES
Basic Shares Outstanding	415.2M shares	392.2M shares
Diluted Shares Outstanding	415.2M shares	392.5M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$360.1M	$763.8M
YoY Change	-52.85%	63550.0%
Cash & Equivalents	$360.1M	$763.8M
Short-Term Investments
Other Short-Term Assets	$31.73M	$40.60M
YoY Change	-21.85%
Inventory	$25.85M
Prepaid Expenses	$6.846M
Receivables	$1.339M
Other Receivables	$0.00
Total Short-Term Assets	$419.0M	$804.4M
YoY Change	-47.91%	66932.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$264.1M	$123.4M
YoY Change	114.0%
Goodwill	$5.238M	$5.238M
YoY Change	0.0%
Intangibles	$97.18M	$50.00M
YoY Change	94.36%
Long-Term Investments	$62.63M	$7.312M
YoY Change	756.59%
Other Assets	$3.353M	$0.00
YoY Change		-100.0%
Total Long-Term Assets	$491.3M	$198.9M
YoY Change	146.99%	-16.52%
TOTAL ASSETS
Total Short-Term Assets	$419.0M	$804.4M
Total Long-Term Assets	$491.3M	$198.9M
Total Assets	$910.4M	$1.003B
YoY Change	-9.26%	318.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$77.48M	$40.80M
YoY Change	89.9%	40700.0%
Accrued Expenses	$108.2M	$29.00M
YoY Change	273.1%	28900.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$507.0K	$0.00
YoY Change
Total Short-Term Liabilities	$183.6M	$70.97M
YoY Change	158.76%	5359.31%
LONG-TERM LIABILITIES
Long-Term Debt	$25.05M	$13.70M
YoY Change	82.81%
Other Long-Term Liabilities	$72.23M	$6.400M
YoY Change	1028.61%
Total Long-Term Liabilities	$72.23M	$20.10M
YoY Change	259.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$183.6M	$70.97M
Total Long-Term Liabilities	$72.23M	$20.10M
Total Liabilities	$288.2M	$91.04M
YoY Change	216.57%	6902.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.404B	-$680.4M
YoY Change	106.28%
Common Stock	$42.00K	$39.00K
YoY Change	7.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$622.2M	$912.3M
YoY Change
Total Liabilities & Shareholders Equity	$910.4M	$1.003B
YoY Change	-9.26%	318.92%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$152.9M	-$120.2M
YoY Change	27.21%	262.71%
Depreciation, Depletion And Amortization	$3.111M	$1.805M
YoY Change	72.35%	28.2%
Cash From Operating Activities	-$131.3M	-$59.25M
YoY Change	121.65%	170.58%
INVESTING ACTIVITIES
Capital Expenditures	-$30.11M	-$24.52M
YoY Change	22.78%
Acquisitions
YoY Change
Other Investing Activities	-$3.348M
YoY Change
Cash From Investing Activities	-$33.45M	-$24.52M
YoY Change	36.43%	1604.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$27.38M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$27.65M	-$1.758M
YoY Change	-1673.04%	-113.37%
NET CHANGE
Cash From Operating Activities	-$131.3M	-$59.25M
Cash From Investing Activities	-$33.45M	-$24.52M
Cash From Financing Activities	$27.65M	-$1.758M
Net Change In Cash	-$137.1M	-$85.53M
YoY Change	60.33%	739.74%
FREE CASH FLOW
Cash From Operating Activities	-$131.3M	-$59.25M
Capital Expenditures	-$30.11M	-$24.52M
Free Cash Flow	-$101.2M	-$34.73M
YoY Change	191.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001731289
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-38495
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Nikola Corporation
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	140000	USD
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4151153
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4141 E Broadway Road
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Phoenix
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85040
CY2022Q1	dei	City Area Code CityAreaCode	480
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	666-1038
CY2022Q1	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	NKLA
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Inventory Net InventoryNet	25847000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	11597000	USD
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	421138281	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	360118000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	497241000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1339000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31730000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15891000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	419034000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	524729000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	25000000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	25000000	USD
CY2022Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	33800000	USD
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	27620000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	264121000	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	244377000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	97181000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	97181000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	62634000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	61778000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	5238000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	5238000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3353000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3896000	USD
CY2022Q1	us-gaap	Assets Assets	910361000	USD
CY2021Q4	us-gaap	Assets Assets	989819000	USD
CY2022Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	77478000	USD
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	86982000	USD
CY2022Q1	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	105657000	USD
CY2021Q4	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	93487000	USD
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	507000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2263000	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4718000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	183642000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	180609000	USD
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	25045000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	25047000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2542000	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4284000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	72231000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	84033000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	11000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	11000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	288189000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	296247000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	418344072	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	418344072	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	413340550	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	413340550	shares
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1403553000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	42000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2025552000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1944341000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1250612000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	131000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-198000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	622172000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	693572000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	910361000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	989819000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1887000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1456000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	415152656	shares
CY2022Q1	us-gaap	Gross Profit GrossProfit	431000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	0	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	74557000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55163000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	77183000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	65427000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	151740000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	120590000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-151309000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-120590000	USD
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-211000	USD
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-9000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	434000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-951000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1833000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	219000	USD
CY2022Q1	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-150121000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-150121000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-119429000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
CY2021Q1	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-119430000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2820000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-794000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-152941000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-120224000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	415152656	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	392189851	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	392489761	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-152941000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-120224000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	329000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-313000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-152612000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-120537000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	693572000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	308000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27376000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	53528000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-152941000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	329000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	622172000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	980141000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2413000	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	3473000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	50266000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-120224000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-313000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	912283000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-152941000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-120224000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3111000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1805000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	53528000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	50266000	USD
CY2022Q1	nkla	Non Cash In Kind Services NonCashInKindServices	0	USD
CY2021Q1	nkla	Non Cash In Kind Services NonCashInKindServices	12896000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2820000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-794000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	434000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-951000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	326000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1339000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	22404000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	14710000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1758000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2131000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2083000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4161000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	304000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-77000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-457000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-131323000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-59249000	USD
CY2022Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	30106000	USD
CY2021Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	24521000	USD
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3348000	USD
CY2021Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33454000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24521000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	308000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2626000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	27376000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	30000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	258000	USD
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	4100000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	26000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27654000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1758000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-137123000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-85528000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	522241000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849278000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	385118000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	763750000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	273000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	187000	USD
CY2022Q1	nkla	Interest Received InterestReceived	85000	USD
CY2021Q1	nkla	Interest Received InterestReceived	259000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	21294000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	27108000	USD
CY2022Q1	nkla	Accrued Deferred Issuance Costs AccruedDeferredIssuanceCosts	0	USD
CY2021Q1	nkla	Accrued Deferred Issuance Costs AccruedDeferredIssuanceCosts	330000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	378000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	360100000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	497200000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	25000000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	25000000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	360118000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	497241000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	763750000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	25000000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	25000000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	385118000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	522241000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	763750000	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4718000	USD
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	3752000	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4284000	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	4189000	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y2M4D
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y5M1D
CY2020Q4	nkla	Period Of Derivative Action PeriodOfDerivativeAction	P30D
CY2022Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	12766000	USD
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7344000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	8556000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4253000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4525000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	25847000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	11597000	USD
CY2022Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	17014000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	5615000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6846000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5116000	USD
CY2022Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	5713000	USD
CY2021Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	2717000	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2157000	USD
CY2021Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2443000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31730000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15891000	USD
CY2022Q1	us-gaap	Grants Receivable GrantsReceivable	300000	USD
CY2021Q1	us-gaap	Grants Receivable GrantsReceivable	0	USD
CY2021Q1	nkla	Period Of Derivative Action PeriodOfDerivativeAction	P30D
CY2022Q1	us-gaap	Grants Receivable Current GrantsReceivableCurrent	2400000	USD
CY2022Q1	us-gaap	Grants Receivable Noncurrent GrantsReceivableNoncurrent	300000	USD
CY2021Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	1200000	USD
CY2021Q4	us-gaap	Grants Receivable Noncurrent GrantsReceivableNoncurrent	1200000	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	283653000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	260884000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	19532000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	16507000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	264121000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	244377000	USD
CY2022Q1	nkla	Property Plant And Equipment And Finance Lease Right Of Use Asset Construction In Process Placed Into Service PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetConstructionInProcessPlacedIntoService	26800000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	3000000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	1800000	USD
CY2022Q1	nkla	Accrued Settlement Cost AccruedSettlementCost	50000000	USD
CY2021Q4	nkla	Accrued Settlement Cost AccruedSettlementCost	50000000	USD
CY2022Q1	nkla	Accrued Purchase Of Intangible Asset AccruedPurchaseOfIntangibleAsset	22231000	USD
CY2021Q4	nkla	Accrued Purchase Of Intangible Asset AccruedPurchaseOfIntangibleAsset	11344000	USD
CY2022Q1	nkla	Goods Received Not Yet Invoiced GoodsReceivedNotYetInvoiced	11526000	USD
CY2021Q4	nkla	Goods Received Not Yet Invoiced GoodsReceivedNotYetInvoiced	8253000	USD
CY2022Q1	nkla	Accrued Legal Liabilities Current AccruedLegalLiabilitiesCurrent	6059000	USD
CY2021Q4	nkla	Accrued Legal Liabilities Current AccruedLegalLiabilitiesCurrent	5664000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4848000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2521000	USD
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3752000	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4189000	USD
CY2022Q1	nkla	Accrued Purchases Of Property And Equipment Current AccruedPurchasesOfPropertyAndEquipmentCurrent	2897000	USD
CY2021Q4	nkla	Accrued Purchases Of Property And Equipment Current AccruedPurchasesOfPropertyAndEquipmentCurrent	2817000	USD
CY2022Q1	nkla	Accrued Outsourced Engineering Services Current AccruedOutsourcedEngineeringServicesCurrent	2546000	USD
CY2021Q4	nkla	Accrued Outsourced Engineering Services Current AccruedOutsourcedEngineeringServicesCurrent	1134000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1798000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7565000	USD
CY2022Q1	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	105657000	USD
CY2021Q4	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	93487000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	62634000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	61778000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2820000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-794000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	361000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	140000	USD
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	507000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	140000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	535000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	408000	USD
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	25045000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	25047000	USD
CY2021Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	25000000	USD
CY2022Q1	nkla	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	750000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	400000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1000000	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4700000	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4300000	USD
CY2021Q2	nkla	Sale Of Stock Purchase Period SaleOfStockPurchasePeriod	P36M
CY2021Q2	nkla	Issuance Of Stock For Commitment Shares IssuanceOfStockForCommitmentShares	2600000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28996160	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.28
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M13D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	179831	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.71
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	15225	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.16
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28801104	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.27
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M13D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	28470051	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.25
CY2022Q1	nkla	Loss Contingency Period To File Opposition LossContingencyPeriodToFileOpposition	P30D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y7M9D
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	53528000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50266000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	294239000	USD
CY2021Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-125000000	USD
CY2021Q4	nkla	Loss Contingency Number Of Installment Payments LossContingencyNumberOfInstallmentPayments	5	installment
CY2021Q4	nkla	Loss Contingency Installment Payment Period LossContingencyInstallmentPaymentPeriod	P2Y
CY2020Q3	nkla	Number Of Class Action Lawsuits NumberOfClassActionLawsuits	6	lawsuit
CY2020Q3	nkla	Number Of Derivative Actions NumberOfDerivativeActions	2	derivativeAction
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-152941000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-120224000	USD
CY2022Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2021Q1	us-gaap	Dilutive Securities DilutiveSecurities	-951000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-152941000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-121175000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	415152656	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	392189851	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	299910	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	415152656	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	392489761	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57784874	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50958970	shares

Files In Submission

Name	View Source	Status
0001731289-22-000085-index-headers.html	Edgar Link	pending
0001731289-22-000085-index.html	Edgar Link	pending
0001731289-22-000085.txt	Edgar Link	pending
0001731289-22-000085-xbrl.zip	Edgar Link	pending
exhibit311q122.htm	Edgar Link	pending
exhibit312q122.htm	Edgar Link	pending
exhibit321q122.htm	Edgar Link	pending
exhibit322q122.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nkla-20220331.htm	Edgar Link	pending
nkla-20220331.xsd	Edgar Link	pending
nkla-20220331_cal.xml	Edgar Link	unprocessable
nkla-20220331_def.xml	Edgar Link	unprocessable
nkla-20220331_htm.xml	Edgar Link	completed
nkla-20220331_lab.xml	Edgar Link	unprocessable
nkla-20220331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NKLA
Nikola Corp Stock $nkla

2022 Q1 Form 10-Q Financial Statement

#000173128922000085 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NKLA Nikola Corp Stock $nkla

2022 Q1 Form 10-Q Financial Statement

#000173128922000085 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NKLA
Nikola Corp Stock $nkla